NuVasive's executive sells 7k+ shares: 4 things to know

Spinal Tech

NuVasive's Matthew Link, president of U.S. sales and services, has sold 7,500 shares in a March 3 transaction, according to a Wall Street Pulse report.

Here four things to know:

 

1. Mr. Link sold the shares at $44.46 per share.

 

2. The total value of transaction was $333,450.

 

3. The 52-week high of the shares is $51.23 and the 52-week low is $31.35.

 

4. NuVasive received an average rating of "buy" for the short term.

More articles on devices:

NuVasive, Medtronic patent saga continues — 5 key updates
InVivo goes from illiquid to a top-traded stock: 5 key notes
6 key notes on Mazor Robotics' short interest decline

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers